Condition Deep-Dives 10 min read·Updated 22 July 2026 Clinician-reviewed

MPGN and C3 Glomerulopathy

A UK Consultant Nephrologist's deep-dive on membranoproliferative glomerulonephritis and the complement-driven C3 glomerulopathies — rare, complex, and now finally treatable as targeted complement inhibitors enter UK practice.

  • Clinically Reviewed
  • NHS & NICE Aligned
  • UK Evidence-Based
  • Last Reviewed 22 July 2026

Professor Mohammed Mahdi Althaf

Consultant Nephrologist & Acute Physician

View Credentials

Professor Mohammed Mahdi Althaf

MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN

Consultant Nephrologist & Acute Physician · GMC 7216325

View profile →

Direct answer

MPGN is a biopsy pattern, not a diagnosis. Always look for the cause: hepatitis C, monoclonal gammopathy, autoimmune disease, or alternative complement pathway dysregulation (C3 glomerulopathy). Complement inhibitors are transforming care of C3GN and DDD.

Key recommendation: MPGN = pattern of injury, not a single disease.

Quick answer

✓ Best choices

  • Plant proteins: beans, lentils, tofu, tempeh, chickpeas
  • Vegetables, fruit and whole grains
  • Oily fish 1–2 times a week
  • Olive oil as the main cooking fat

✓ Foods to limit

  • Added salt (≤ 6 g/day)
  • Processed meats and high-additive ready meals
  • Excess animal protein at every meal

Key takeaway

MPGN is a biopsy pattern, not a diagnosis. Always look for the cause: hepatitis C, monoclonal gammopathy, autoimmune disease, or alternative complement pathway dysregulation (C3 glomerulopathy). Complement inhibitors are transforming care of C3GN and DDD.

Who should be cautious

People on dialysis, post-transplant, pregnant or breastfeeding, or taking prescription medication — confirm with your renal team before changes.

MPGN and C3 Glomerulopathy

Biopsy patterns and classification

Light Microscopy

  • Lobular glomeruli with mesangial expansion
  • Double-contour 'tram-track' GBM (silver stain)
  • Mesangial and endocapillary hypercellularity
  • Crescents in severe cases

IMMUNOFLUORESCENCE — the key discriminator:

  • Bright C3 only → C3 glomerulopathy
  • C3 + immunoglobulins (IgG, IgM) → immune complex MPGN
  • Light-chain restriction (kappa or lambda) → monoclonal gammopathy of renal significance (MGRS)

Electron Microscopy

  • Subendothelial deposits → typical MPGN
  • Intramembranous dense deposits → dense deposit disease (DDD)
  • Mesangial and subepithelial deposits → C3GN

Modern Classification

1. Immune complex / monoclonal Ig MPGN — secondary to infection, autoimmunity or paraprotein 2. C3 glomerulopathy: a) C3 glomerulonephritis (C3GN) b) Dense deposit disease (DDD)

Causes to work through

IMMUNE COMPLEX MPGN — always search for:

  • Hepatitis C (commonest in UK adults)
  • Hepatitis B
  • Bacterial endocarditis, shunt nephritis, deep abscess
  • SLE (lupus nephritis class IV often shows MPGN pattern)
  • Sjögren's, RA, cryoglobulinaemia
  • Monoclonal gammopathy — MGRS

C3 GLOMERULOPATHY — investigate:

  • C3 nephritic factor (C3NeF) — stabilises C3 convertase
  • Factor H, factor I, MCP gene mutations
  • Factor H autoantibodies
  • MCP, CFHR1-5 rearrangements
  • Rare: paraprotein driving complement dysregulation

Investigations

  • Hepatitis B/C, HIV serology
  • ANA, anti-dsDNA, complement (C3, C4)
  • Serum + urine immunofixation, serum free light chains
  • Cryoglobulins
  • Echocardiogram if endocarditis suspected
  • Alternative pathway functional assay
  • Genetic screening — UK National Renal Complement Therapeutics Centre (Newcastle)

Kidney Vitality is a daily multivitamin developed by a UK Consultant Nephrologist using renal nutrition principles. It contains no added potassium, magnesium, phosphorus or iron, and no herbal blends. See the formulation.

Treatment in 2026

General For All

  • ACE inhibitor or ARB — first-line
  • BP target <130/80
  • Statin
  • Salt restriction
  • Treat fluid overload
  • SGLT2 inhibitor — strong rationale in proteinuric CKD (eGFR ≥20)

Immune Complex MPGN

  • Treat the underlying cause:
  • Hepatitis C: direct-acting antivirals (DAAs) — often resolves the GN
  • Hepatitis B: tenofovir/entecavir
  • Endocarditis: source control + antibiotics
  • Lupus: standard induction (MMF or cyclophosphamide + steroids ± belimumab)
  • MGRS: clone-directed therapy (e.g. bortezomib + dexamethasone for plasma cell clones, rituximab for B-cell clones) — managed jointly with haematology

C3 Glomerulopathy

  • Supportive RAAS blockade for mild disease
  • Mycophenolate + tapering prednisolone for active disease (KDIGO 2024)
  • Rituximab if associated B-cell clone
  • Eculizumab — variable response, used selectively
  • Iptacopan (factor B inhibitor) — first oral complement inhibitor approved in C3G in 2024; transforming outcomes
  • Pegcetacoplan and avacopan — under investigation
  • Plasma exchange in fulminant / crescentic disease

Monitor

  • Urine PCR/ACR every 1-3 months
  • eGFR every 1-3 months
  • Complement profile, C3NeF if positive at baseline
  • Repeat biopsy if uncertain response

Outlook and transplant

Prognosis

  • Immune complex MPGN — outcome driven by the underlying cause; HCV-related MPGN now often curable
  • C3 glomerulopathy — historically 50% reached kidney failure within 10 years; outlook improving with complement inhibitors
  • Dense deposit disease — most aggressive; childhood/adolescent onset typical

Transplant

  • High recurrence risk (especially DDD ~50-90%, C3GN ~50%)
  • Pre-transplant complement work-up at the National Renal Complement Therapeutics Centre
  • Eculizumab or iptacopan prophylaxis considered for high-risk recipients
  • Living donation requires donor genetic screening if a familial complement mutation is identified

Key Messages

  • Never accept 'MPGN' as a diagnosis — find the cause
  • Send tissue to a centre familiar with complement disease for thorough work-up
  • Refer C3 glomerulopathy and MGRS-MPGN to a specialist centre
Lupus Nephritis
Related reading: Lupus Nephritis.

Key practical tips

Designed for quick scanning — what to order, what to avoid, sensible portions, common mistakes.

  • Take prescribed ACE inhibitor / ARB / SGLT2 inhibitor consistently — diet works alongside, not instead
  • Monitor BP at home weekly
  • Review urine ACR with your team to track progress

Clinical guidance

TL;DR summary

MPGN is a biopsy pattern, not a diagnosis. Always look for the cause: hepatitis C, monoclonal gammopathy, autoimmune disease, or alternative complement pathway dysregulation (C3 glomerulopathy). Complement inhibitors are transforming care of C3GN and DDD.

Key takeaways
  • MPGN = pattern of injury, not a single disease.
  • Modern classification: immune-complex vs complement-mediated (C3G).
  • C3G includes C3GN and dense deposit disease (DDD).
  • Hunt for hepatitis C, monoclonal gammopathy, autoimmunity.
  • Complement inhibitors (iptacopan) are changing C3G outcomes.
Kidney Diet & Nutrition Considerations

When protein is leaking into the urine, the goal is to protect the remaining kidney function. Dietary protein should be sensible — neither very high nor unnecessarily low — and a Mediterranean-style plate with reduced salt supports both blood pressure and albuminuria reduction alongside ACE inhibitors, ARBs or SGLT2 inhibitors.

Foods to prioritise

  • Plant proteins: beans, lentils, tofu, tempeh, chickpeas
  • Vegetables, fruit and whole grains
  • Oily fish 1–2 times a week
  • Olive oil as the main cooking fat

Foods to limit

  • Added salt (≤ 6 g/day)
  • Processed meats and high-additive ready meals
  • Excess animal protein at every meal

Potassium, phosphate and protein needs vary between individuals — please confirm personal targets with your renal team or dietitian. Browse the Kidney Diet Hub for more guides in this cluster.

Frequently asked questions

What is MPGN?

Membranoproliferative glomerulonephritis is a pattern of injury on kidney biopsy — thickened glomerular basement membranes with mesangial proliferation and a 'tram-track' appearance on silver stain. It is not a single disease but a final common pathway from immune complex deposition or complement dysregulation.

How is MPGN classified now?

The old types I/II/III system has been replaced by a mechanism-based classification: (1) Immune complex-mediated MPGN (driven by infections like hepatitis C, autoimmune disease, monoclonal gammopathy), and (2) Complement-mediated MPGN — now called C3 glomerulopathy, which includes C3 glomerulonephritis and dense deposit disease (DDD).

What causes C3 glomerulopathy?

Uncontrolled activation of the alternative complement pathway. Causes include C3 nephritic factor (an autoantibody that stabilises the C3 convertase), mutations in complement regulators (factor H, factor I, MCP) and rarely monoclonal gammopathy. The complement system attacks the glomerulus continuously.

Is there a treatment?

For immune-complex MPGN — treat the underlying cause (e.g. DAAs for hepatitis C, immunosuppression for autoimmune disease, clone-directed therapy for monoclonal gammopathy). For C3 glomerulopathy — supportive care (ACE/ARB, BP control), mycophenolate + steroids in active disease, and emerging complement inhibitors (iptacopan, pegcetacoplan) now in trials and entering practice.

Can diet reduce protein in urine?

A reduced-salt, Mediterranean-style diet with sensible protein intake can lower urine protein, particularly when combined with prescribed ACE inhibitors, ARBs or SGLT2 inhibitors. Very low-protein diets are not routinely recommended without dietitian supervision.

Nutritional challenges in kidney disease

Many people living with kidney disease have to limit foods because of potassium, phosphate, diabetes, dialysis, appetite changes or simply the time it takes to cook from scratch every day. That can make it harder to keep daily nutrition balanced — particularly for vitamins and minerals that food alone may not fully cover.

Kidney Vitality is a UK-formulated daily nutritional support product designed by Consultant Nephrologist Professor Mohammed Mahdi Althaf with renal nutrition in mind from the start. It keeps doses moderate, leaves out added potassium, phosphate and magnesium, and avoids megadose vitamin A — sitting alongside a kidney-friendly diet, not replacing it.

Why Kidney Vitality fits this need

Built around UK renal guidance

Aligned with KDIGO 2024 GN guidelines and the UK National Renal Complement Therapeutics Centre pathway.

Designed by a UK Consultant Nephrologist

Formulated and reviewed by Professor Mohammed Mahdi Althaf (GMC 7216325).

Up-to-date with 2026 complement therapy

Reflects the recent approval of iptacopan in C3 glomerulopathy and emerging complement inhibitors.

Designed by a UK Consultant Nephrologist

Ready to support your kidney health?

If you have been researching kidney health, supplements, CKD nutrition or kidney-friendly living, Kidney Vitality was developed specifically around those principles by Professor Mohammed Mahdi Althaf (GMC 7216325). Nephrologist Developed Daily Multivitamin.

  • No Added Potassium
  • No Added Magnesium
  • No Added Phosphorus
  • No Added Iron
  • One capsule daily
  • UK GMP — BRCGS, NSF GMP, Halal
Subscribe & Save — £20.39/monthCheck your current multivitamin

✓ Free UK tracked delivery  ·  ✓ Delivered every 30 days  ·  ✓ Pause or cancel anytime  ·  ✓ Never run out

ComparisonKidney VitalityTypical high-street multivitamin
Added potassiumNoneOften included
Added phosphateNoneOften included (E338–E452)
Vitamin A (retinol)No megadoseOften high-dose retinol
Kidney-focused formulationYesNo — general population
Consultant Nephrologist involvementYes (GMC 7216325)No
UK GMP manufacturedYes (BRCGS, NSF GMP)Varies

Food supplement. Not a medicine and not a treatment for kidney disease. Speak with your GP, pharmacist or renal team before starting any new supplement, especially in advanced CKD, on dialysis, post-transplant, pregnant or breastfeeding.

Clinical reviewer

Professor Mohammed Mahdi Althaf

Consultant Nephrologist

Acute Physician

GMC 7216325

View Full Biography

Professor Mohammed Mahdi Althaf is a UK Consultant Nephrologist and Acute Physician with a special interest in chronic kidney disease, AKI prevention and renal nutrition. He combines hospital practice with patient education and clinical guidance review.

View professional profile →
View Credentials
  • MD
  • MSc
  • PgDip (Clin Ed)
  • FRCP
  • FHEA
  • FASN

About this article

Written for UK patients and based on:

  • NICE guidance
  • NHS resources
  • British Dietetic Association guidance
  • Kidney Care UK resources
View methodology

Each article is researched against current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO and KDOQI international guidelines, and the British Dietetic Association Renal Nutrition Group. Drafts are written by the Kidney Vitality editorial team and reviewed by a UK Consultant Nephrologist before publication. Content is reviewed on a rolling basis and updated when guidance changes.

Editorial standards

  • Clinically reviewed
  • NHS-aligned
  • NICE-aligned
  • Evidence-based
  • Reviewed before publication
View full editorial process

Every article is researched and written by the Kidney Vitality editorial team using current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO/KDOQI international guidelines, and British Dietetic Association renal nutrition guidance. Drafts are reviewed for clinical accuracy by Professor Mohammed Mahdi Althaf, MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN (Consultant Nephrologist & Acute Physician, GMC 7216325) before publication. Content is updated when UK guidance changes.

References (4)View Sources
  1. NICE NG203: Chronic kidney disease — assessment and management
  2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
  3. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update
  4. British Dietetic Association — Renal Nutrition Group

Medical disclaimer

This content is educational only and does not replace personalised medical advice.

Read full disclaimer

This page is general information, not personal medical advice. If you have chronic kidney disease, are on dialysis, have had a kidney transplant, are pregnant or breastfeeding, or take prescription medication, please confirm any supplement with your GP, pharmacist or renal team before starting.

← Back to all guides